Nisa Investment Advisors
DFTX icon

Nisa Investment Advisors’s Definium Therapeutics DFTX Stock Holding History

Nisa Investment Advisors’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.28M Sell
48,369
-534
-1% -$13.2K 0.01% 598
2026
Q1 		$924K Buy
48,903
+525
+1% +$8.91K ﹤0.01% 807
2025
Q4 		$648K Hold
48,378
– – ﹤0.01% 932
2025
Q3 		$570K Buy
48,378
+45,000
+1,332% +$420K ﹤0.01% 986
2025
Q2 		$21.9K Buy
3,378
+945
+39% +$6.21K ﹤0.01% 1892
2025
Q1 		$14.2K Buy
2,433
+2,229
+1,093% +$16K ﹤0.01% 2011
2024
Q4 		$1.42K Buy
+204
New +$1.4K ﹤0.01% 2585
2022
Q2 		– Sell
-1,463
Closed -$24K – 2457
2022
Q1 		$24K Buy
+1,463
New +$25.4K ﹤0.01% 2018

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nisa Investment Advisors's DFTX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Definium Therapeutics (DFTX) stake by 1.1% in Q2 2026, selling an estimated $13.2K and leaving 48,369 shares worth $2.28M. The position accounts for 0.01% of the portfolio, ranked #598.

Nisa Investment Advisors first reported a position in DFTX in Q1 2022 and has held it in 8 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Nisa Investment Advisors held 48,369 shares of Definium Therapeutics worth $2.28M as of Q2 2026.
  • Nisa Investment Advisors sold 534 Definium Therapeutics shares in Q2 2026, an estimated $13.2K.
  • Definium Therapeutics made up 0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #598 holding.
  • Nisa Investment Advisors first reported a position in Definium Therapeutics in Q1 2022 and has held it in 8 quarters since.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.